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Abstract It is known that a characteristic of the mammalian
preimplantation-embryo-speci¢c cell cycle is the substantially
shortened G1-phase, although the regulation mechanisms of
the unique cell cycle remain unclear. In the present study, we
¢rst examined the presence of retinoblastoma (RB) tumor sup-
pressor gene product throughout mouse preimplantation embryo
development and found that the RB expression was down-regu-
lated between the four-cell and morula stages. Furthermore, the
overexpression of RB protein in the mouse embryos during this
phase inhibited their development signi¢cantly. These results
suggest that the absence of RB protein contributes to the pre-
implantation-embryo-speci¢c cell cycle. ' 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Cell cycle progression in preimplantation embryo develop-
ment is independent of exogenous mitogens; i.e. embryos can
undergo cleavage in vitro without the addition of any growth
factors or serum [1]. The period of one cycle is shorter in
embryos than in somatic cells, and the cleaved blastomeres
can enter the next M-phase without any growth in volume
[2,3]. These di¡erences between the embryonic cell cycle and
the somatic cell cycle would be related to the shortened G1-
phase in preimplantation embryo development. At present,
however, the molecular mechanisms of the shortened G1-
phase in preimplantation embryos have not yet been clari¢ed.
In somatic cells, the cell cycle progression is triggered by
extracellular signals [4,5]. When cells are stimulated by a mi-
togen, signal transduction pathways such as the mitogen acti-
vated protein kinase cascade activate and induce the expres-
sion of various genes, including D-type cyclins [6,7]. The
cyclin D synthesis and assembly with their catalytic partners,
CDK4 and CDK6, depend on mitogenic stimulations [8^11],
and cyclin D-dependent kinases phosphorylate some sub-
strates whose modi¢cation is required for the G1/S transition.
Retinoblastoma (RB) protein is one of the major targets phos-
phorylated by cyclin D/cdk 4,6 [9^14].
The RB gene product (pRB) works as a negative growth
regulator that constrains the progression of the cell cycle past
the G1/S transition, and the successful passage from the G1-
to the S-phase requires the inactivation of the pRB function
[4,15^17]. In G1-phase, pRB binds to and represses the E2Fs,
a family of transcriptional regulators, which can transactivate
genes that are important for S-phase entry [18,19]. When pRB
is inactivated by phosphorylation by cyclin D-dependent ki-
nases, the genes required for the G1/S transition are highly
transcribed, and the cells enter S-phase [19,20]. It is postu-
lated, therefore, that pRB is absent or inactivated continu-
ously in preimplantation embryos so that they may enter
the S-phase immediately after the end of the previous
M-phase.
In mouse preimplantation embryos, it was reported that a
high RB mRNA level in the one-cell stage decreased during
the ¢rst and second mitotic cell cycles, and almost no RB
mRNA remained in the late two-cell stage [21]. Although
this report is compatible with the postulate described above,
it represents the only research on RB in preimplantation em-
bryos, and at present no information is available regarding
the period after the four-cell stage in the RB mRNA level or
the period throughout preimplantation embryo development
in the RB protein level. In the present study, we examined the
presence of RB mRNA and RB protein during the mouse
preimplantation embryo development by RT-PCR and immu-
nological techniques, respectively, and showed that RB was
down-regulated in mouse preimplantation embryos. Further-
more, we tried to express pRB in mouse embryos in order to
examine whether pRB repressed the mouse preimplantation
embryo development.
2. Materials and methods
2.1. In vitro fertilization and embryo culture
Embryos were prepared as described previously [22]. Brie£y, female
BDF1 mice (SLC Japan Inc., Tokyo, Japan) were superovulated by
intraperitoneal injection of 7.5 IU pregnant mare serum gonadtropin,
followed 48 h later by 7.5 IU human chorionic gonadtropin (hCG).
Ovulated oocytes were collected 15^16 h after hCG injection from the
ampullae of the oviducts into a modi¢ed Krebs^Ringer bicarbonate
solution (TYH medium) [23]. Spermatozoa were obtained from the
cauda epididymis of male BDF1 mice (SLC Japan Inc.), preincubated
for 1^2 h at 37‡C in TYH medium, and added to the medium con-
taining the oocytes at a concentration of 150 sperm/Wl. After 2 h, the
eggs were treated with 0.05% hyaluronidase (Sigma, St. Louis, MO,
USA) for a few minutes to remove cumulus cells. The eggs were
cultured for up to 120 h after insemination in 5% CO2 in air at
37‡C in Whitten’s medium (WM) [1]. The formation of pronuclei
was examined at 6 h after insemination, and only embryos having
two pronuclei were cultured further. The experiments were conducted
in accordance with the guide for the care and use of laboratory ani-
mals of the College of Agriculture, University of Tokyo.
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2.2. RT-PCR
Total RNA was isolated from 50 eggs or embryos using TRIzoL
reagent (Gibco BRL) according to the manufacturer’s instructions
except for the addition of 20 Wg of glycogen and 20 pg of enhanced
green £uorescent protein (EGFP) mRNA, as carrier and internal con-
trol, respectively. The EGFP mRNA was transcribed in vitro using
the T7 Cap-Scribe kit (Roche). The RNA samples were reverse-tran-
scribed into cDNA using SuperScript II (Gibco BRL) and random
hexamers (Takara) in a ¢nal volume of 20 Wl reaction mixture. The
primers used for the ampli¢cation of the mouse RB sequences were as
follows: 5P-CAACCCCCCCAAACCACTGA-3P (sense) and 5P-CCA-
GATGTAGGGGGTCAGGA-3P (antisense). The primers for EGFP
sequences were described previously [24]. The reaction was performed
with either 33 cycles for RB or 24 cycles for EGFP. Each cycle con-
sisted of 30 s of denaturation at 94‡C, 30 s of annealing at either 58‡C
for RB or 60‡C for EGFP, and 60 s of extension at 72‡C, followed by
a ¢nal extension cycle at 72‡C. The PCR products were separated by
electrophoresis in 2.0% agarose, stained with ethidium bromide, and
photographed under ultraviolet light. For semiquantitative analysis,
EGFP mRNA was added before the isolation of total RNA. This
served as an internal control to evaluate the e⁄ciency of RNA ex-
traction and RT. The appropriate number of cycles of PCR ampli¢-
cation was determined from the exponential range of ampli¢cation for
each set of primers.
2.3. Immunoblotting
One hundred embryos in 1.6 Wl of saline supplemented with 0.1%
polyvinylpyrrolidone were treated with 0.4 Wl of 5U Laemmli’s Bu¡-
er, denatured immediately by boiling for 5 min, and then stored at
380‡C until use. Samples were subjected to modi¢ed SDS^PAGE [22]
on a 7.5% polyacrylamide gel and transferred to Immobilon P (Milli-
pore, Bedford, MA, USA; pore size 0.2 Wm). Following transfer and
blocking for 1 h in 3% skimmed milk in phosphate-bu¡ered saline
(PBS), the membrane was incubated overnight at 4‡C with the anti-
RB antibodies (14001A; Pharmingen) diluted 1:300 in blocking solu-
tion. Bound antibodies were visualized by using horseradish peroxi-
dase-conjugated anti-mouse IgG+IgM (Jackson Immunoresearch
Laboratories) diluted 1:2000 in PBS, followed by enhanced chemilu-
minescent detection (ECL kit; Amersham).
2.4. Immuno£uorescence
Embryos were ¢xed in 4% para-formaldehyde for 30 min and then
permeabilized with 0.5% Triton X-100 in PBS for 10 min. Blocking
was performed with 5% bovine serum albumin (BSA) in PBS for 1 h
at room temperature. The embryos were incubated with anti-RB anti-
bodies (14001A; Pharmingen) diluted 1:100 in blocking solution at
4‡C overnight, and then incubated with secondary rhodamine-conju-
gated goat anti-mouse IgG (Sigma) diluted 1:100 in 5% BSA^PBS for
2 h at room temperature. Samples were ¢nally mounted and observed
under Zeiss confocal laser microscope for the detection of RB.
2.5. Plasmid construction
The RB expression vector pBARB, which contains L-actin pro-
moter and RB cDNA, was kindly provided by Dr. Takahashi (Kyoto
University). To obtain more e¡ective expression plasmid, the open
reading frame of RB was subcloned into the BglII site of pCXN
(kindly provided by Dr. Miyazaki, Osaka University) which contains
CMV-IE enhancer, L-actin promoter and K-globin 3P £anking se-
quence. The pCX-EGFP (a gift from Dr. Okabe, Osaka University)
was used as an expression control.
2.6. Microinjection
The puri¢ed plasmid DNAs were microinjected into the pronuclei
of embryos at 6^9 h after insemination using an Eppendorf pressure
microinjecter and sterile pipets. About 10 pl of the DNA solution
containing around 5^10 pg/Wl was injected per zygote. Microinjection
was performed using a WR-50 microinjection apparatus (Narishige).
The samples were dissolved in injection bu¡er (20 mM HEPES^KOH,
pH 7.4, 120 mM KCl). The embryos were kept in M2 medium
(M7167; Sigma) during the injection periods. After injection, the em-
bryos were washed in WM three times and then cultured in WM at
37‡C, in an atmosphere of 5% CO2 in air.
2.7. Observation of EGFP expression in the embryos
The expression of EGFP in the embryos was observed for £uores-
cence by a £uorescence stereomicroscope (MZ FL III, Leica) at 24,
48, 72, and 96 h after insemination. The embryos were examined their
developmental stage and counted according to the distinguishing
EGFP expression.
2.8. Statistical analyses
The data were analyzed by Student’s t-test. Di¡erences at P6 0.05
were considered to be statistically signi¢cant.
3. Results
3.1. RB expression in mouse preimplantation embryos
First, we examined whether endogenous RB was expressed
during mouse preimplantation embryo development. When
RT-PCR was performed using a set of primers speci¢c for
the mouse RB sequence, RB transcripts were detected before
two-cell embryos and decreased during the ¢rst mitotic cell
cycle (Fig. 1A, lanes 1^3) as described previously [21].
Although RB mRNA was not detected between the four-cell
embryo and early blastocyst embryo at 96 h of culture, RB
was transcribed again in the late blastocyst stage embryo at
120 h (Fig. 1A, lanes 4^8). When the immunoblotting was
performed using anti-RB monoclonal antibody, clear bands
speci¢c for pRB were detected before 24 h of culture at ap-
proximately 105 kDa (Fig. 1B, lanes 1^3). In contrast, no
bands were detected from the late two-cell embryo at 36 h
to the early blastocyst embryo at 108 h of culture (Fig. 1B,
lanes 4^10). In the late blastocyst stage at 120 h, however, a
clear band speci¢c for pRB was detected (Fig. 1B, lane 11).
The presence of pRB in the blastocyst but not in the earlier
stage embryos was also shown by immunocytochemical anal-
yses (Fig. 1C). These results suggest that there were no or few
RB expressions in mouse embryos from the late two-cell to
the early blastocyst stages.
3.2. Overexpression of pRb in mouse embryos
Next we tried to overexpress pRB in mouse embryos before
the morula stage. As it has been reported that the transient
protein expression rate of mouse early embryos injected with a
vector-DNA into the pronucleus was less than 50% of that of
the manipulated embryos [24,25], we attempted to distin-
guished the embryo expressing pRB from the non-expressing
embryos. For this purpose, pCAG-EGFP and pCAG-RB
were co-injected into pronuclei and it was determined whether
EGFP could be used as the marker of pRB expression or not.
The expression of EGFP was observed within 15^18 h after
injection (24 h after insemination, Fig. 2A) and the expression
rate was about 50% of that of the embryos injected with
plasmids (Fig. 2B). The expression rate increased gradually
and reached 70% at 63^66 h after injection (72 h after insemi-
nation). The high expression rate was maintained until 96 h
after insemination (Fig. 2B). There were no di¡erences in the
EGFP expression rate of embryos between the only pCAG-
EGFP injected group and the group co-injected with pCAG-
EGFP and pCAG-RB (Fig. 2B). When EGFP-positive and -
negative embryos in the co-injected groups were classi¢ed and
subjected to immunoblotting against pRB, a clear pRB signal
was detected only in the EGFP-positive embryos (Fig. 2C).
Furthermore, when immuno£uorescent staining against pRb
was performed in the co-injected embryos at 48 h after in-
semination, the pRB signal was also obtained only in the
EGFP-positive embryos (Fig. 2D). These results suggest that
EGFP might be a powerful marker of protein expression.
FEBS 26379 16-8-02 Cyaan Magenta Geel Zwart
N. Iwamori et al./FEBS Letters 526 (2002) 119^123120
3.3. E¡ect of pRb expression on mouse preimplantation embryo
development
As there were no di¡erences in the rate of EGFP-negative
embryos between the group injected with pCAG-EGFP alone
and the group co-injected with pCAG-EGFP and pCAG-RB,
their rates are combined in Fig. 3 as EGFP-negative. Most of
the EGFP-negative embryos developed into the two-cell,
four-cell, morula and blastocyst stages at 24, 48, 72 and
96 h of culture, respectively. The frequencies of these em-
bryos are shown in Fig. 3. The EGFP-positive embryos
injected with pCAG-EGFP alone and the EGFP-negative
embryos were equally developed. However, the development
of the EGFP-positive embryos co-injected with pCAG-RB,
which might overexpress pRB, was deteriorated in compar-
ison with the EGFP-negative embryos and EGFP-positive
embryos injected with pCAG-EGFP alone, and most of
embryos expressing pRB arrested before the morula stage
(Fig. 3). These results suggest that pRB repressed the cell
cycle progression during preimplantation embryo develop-
ment.
4. Discussion
In this report, we showed for the ¢rst time the temporal
pattern of the expression of RB at the mRNA and protein
levels throughout mouse preimplantation embryo develop-
ment. The expression of RB has been reported in the mouse
from immature oocytes to the two-cell stage embryos at the
mRNA level only by the RT-PCR method [21]. That earlier
report showed that the RB mRNA remained at a high level
until 12 h after fertilization and decreased thereafter to a basal
level at the two-cell stage 32 h after fertilization. Our present
¢ndings agreed well with this previous result. Furthermore, we
showed that RB mRNA expression did not begin again until
the blastocyst stage, when the ¢rst di¡erentiation appeared. In
addition, we examined RB expression at the protein level and
obtained the same results, which showed the absence of pRB
from the late two-cell to the mid-blastocyst stages. These re-
sults suggest the relationship of the absence of pRB to the
preimplantation-embryo-speci¢c cell cycle progression. In
mammalian preimplantation embryos, the G1-phase is sub-
Fig. 1. RB expression during preimplantation development of the mouse embryo. A: PCR products ampli¢ed from cDNA prepared from the
RNA from each 50 of oocytes or embryos at indicated stages. RB cDNA was ampli¢ed using speci¢c primers. EGFP was the internal control
for semiquantitative analysis. B: Each 100 unfertilized oocytes or embryos at the indicated stages were collected and subjected to immunoblot-
ting with an anti-RB antibody. Arrow indicates RB-speci¢c band. C: Embryos cultured for 48 h (a,b) and 108 h (c,d) were collected and
stained with a control mouse IgG (a,c) and an anti-RB antibody (b,d). The antibodies were visualized with an anti mouse IgG antibody conju-
gated with rhodamine.
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stantially shortened, and DNA synthesis is started soon after
mitosis [21,26], which indicate the presence of all of the mol-
ecules required for the G1/S transition during the preceding
M-phase or throughout the cell cycle. In somatic cells, the
expression of the molecules required for the G1/S transition
is regulated by the transcription factor, E2F, which is inhib-
ited by pRB binding [18,19]. The absence of pRB from the
four-cell stage to the morula stage in mouse embryos, there-
fore, might induce the constitutive activation of E2F and the
accumulation of these molecules in order to start DNA syn-
thesis soon after the decondensation of chromosomes.
There is a dramatic change in gene expression at the two-
cell stage of mouse embryos, known as zygotic gene activation
(ZGA), when the embryonic genome starts to be transcribed
[27^29]. It has been well accepted that most proteins and
RNAs present before ZGA are maternal factors and most
of them are degraded at ZGA. The present study showed
that RB was one of those maternal factors. Although RB
was expressed during the two-cell stage, the G1-phase remains
short in this embryonic cell cycle. This fact indicates that the
inactivation of pRB function is not necessary for the start of
the S-phase in the mouse embryo before ZGA, probably be-
cause all of the molecules required for the G1/S transition are
also maternal factors and already present in the embryos as
reported in Xenopus embryos [30].
Next, we tried to overexpress pRB during mouse preim-
plantation embryo development in order to clarify the rela-
tionship of absence of pRB to the preimplantation-embryo-
speci¢c cell cycle. It has been reported that the transient pro-
tein expression rate of mouse preimplantation embryos in-
jected with a vector-DNA into the pronucleus was about
40% of the injected embryos [24,25]. To get more de¢nitive
results, therefore, we tried to select the embryos expressing
pRB by co-injecting of the EGFP vector DNA with the RB
vector DNA as an expression marker. In the present study,
EGFP was expressed by 50% of embryos injected either with
EGFP vector alone or an EGFP and RB vector mixture, and
the expression rate was maintained of more than 50% there-
after. These results are quite compatible with the previous
reports, thus showing the reliability of the present experi-
ments. Furthermore, we found that only the EGFP-expressing
embryos expressed pRB in the nucleus, which indicated the
usefulness of the EGFP-vector co-injection as the marker of
RB expression.
The preimplantation embryo development was heavily in-
hibited by the pRB expression, and the majority of the em-
bryos expressing pRB could not develop over the four-cell
stage. This inhibitory e¡ect was speci¢c for pRB because
the development of embryos expressing only EGFP was com-
patible with that of embryos without protein expression. Most
of the stopped embryos were morphologically not degenerated
but were rather arrested at the two- to four-cell stages. This
result is compatible with the hypothesis that maternal factors
required for the G1/S transition are present in the one-cell
Fig. 2. Expression of exogenous RB protein in embryos injected with the vector DNAs into the pronucleus. A: A typical example of the co-in-
jected embryos cultured for 56 h. The same ¢eld was examined under normal light (upper panel) and EGFP excitation light (lower panel).
B: The rate of EGFP-positive embryos microinjected with pCAG-EGFP alone (open circle) and co-injected with pCAG-EGFP and pCAG-RB
(closed circle). Embryos were cultured in WM until 96 h after DNA microinjection and examined under the EGFP excitation light (488 nm) at
the indicated culture periods. C: Detection of exogenous RB protein in embryos injected with the mixture of pCAG-EGFP and pCAG-RB.
Embryos were cultured in WM for 72 h (63^66 h after microinjection), then EGFP-positive (left) and -negative (right) embryos were subjected
to immunoblotting with an anti-RB antibody. Arrow indicates the RB-speci¢c band. D: Typical examples of the EGFP-positive (a,b) and -neg-
ative (c,d) embryos collected at 48 h after insemination (39^42 h after microinjection) and stained with an anti-RB antibody (a,c). The embryos
were examined by phase contrast microscopy (b,d) or immuno£uorescent microscopy for detecting the anti-RB antibody with an anti mouse
IgG antibody conjugated with rhodamine.
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stage embryos but are degraded during the two-cell stage of
mouse embryos, and E2F-dependent transcription is a prereq-
uisite for the entrance into the S-phase after the four-cell
stage. Exogenous pRB might suppress the embryo from enter-
ing the S-phase by inhibiting of E2F activation. The expres-
sion of pRB in normal mouse blastocysts in the present study
suggests that the preimplantation-embryo-speci¢c cell cycle
changes into the somatic cell cycle, which has a long G1-
phase, at this developmental stage.
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Fig. 3. Developmental rates of embryos expressed exogenous RB
protein. Embryos were injected with pCAG-EGFP alone or the mix-
ture of pCAG-EGFP and pCAG-RB, then cultured up to 96 h after
the microinjection of DNAs. The rates of embryos developed to the
two-cell, four-cell, morula, and blastocyst stages at 24, 48, 72, and
96 h, respectively, are shown. The white bar represents the rate of
EGFP-negative embryos of both groups. The hatched bar and black
bar represent the rates of EGFP-positive embryos in the pCAG-
EGFP injected and pCAG-EGFP and pCAG-RB co-injected
groups, respectively. The values with asterisks were signi¢cantly dif-
ferent from the embryos without expressing RB.
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